Detail akcie Bio Rad online

Business Summary: Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Bio Rad Laboratories Inc revenues decreased 4% to $585.4M. Net income decreased 83% to $64M. Revenues reflect Life Science segment decrease of 5% to $228.6M, Clinical Diagnostics segment decrease of 3% to $356.8M, APAC segment decrease of 11% to $104.1M, United States segment decrease of 4% to $241.7M. Net income also reflects Losses from change in fair market value decrease of 92% to $31.8M (income).